EditorialKommentar
Chelation Therapy Following Myocardial Infarction
JAMA · 2024
DOI: 10.1001/jama.2024.13549 ↗Kurz gefasst
Editorial in der Zeitschrift JAMA, 2024. Verfasst von Gregory Curfman. Beteiligte Einrichtung: Executive Editor, JAMA. Hauptthemen laut MEDLINE: Chelating Agents, Chelation Therapy, Myocardial Infarction, Edetic Acid. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Chelating AgentsChelation TherapyMyocardial InfarctionEdetic AcidHumansInfusions, IntravenousDiabetes MellitusCadmiumLeadSecondary PreventionRandomized Controlled Trials as TopicTreatment Outcome
Substanzen
Chelating AgentsEdetic AcidCadmiumLead
Autor:innen und Institutionen
- Executive Editor, JAMA.
Zitieren
APA
Curfman, G. (2024). Chelation Therapy Following Myocardial Infarction. JAMA. https://doi.org/10.1001/jama.2024.13549
Vancouver
Curfman G. Chelation Therapy Following Myocardial Infarction. JAMA. 2024. doi:10.1001/jama.2024.13549
BibTeX
@article{Curfman2024,
author = {Curfman, Gregory},
title = {Chelation Therapy Following Myocardial Infarction},
journal = {JAMA},
year = {2024},
doi = {10.1001/jama.2024.13549}
}
EUVIMED